JMP Securities Starts Constellation Pharmaceuticals (CNST) at Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CNST Hot Sheet
Price: $33.99 --0%
Rating Summary:
3 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
3 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
JMP Securities analyst Reni Benjamin initiates coverage on Constellation Pharmaceuticals (NASDAQ: CNST) with a Market Perform rating and a price target of $36.00.
For an analyst ratings summary and ratings history on Constellation Pharmaceuticals click here. For more ratings news on Constellation Pharmaceuticals click here.
Shares of Constellation Pharmaceuticals closed at $30.43 yesterday.
You May Also Be Interested In
- Stifel Starts ATHA Energy Corp. (SASK:CN) at Buy
- H.C. Wainwright Starts Insmed (INSM) at Buy
- CLSA Starts Busy Ming Group (1768:HK) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
